LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
11.14
-0.31 (-2.75%)
Jul 22, 2026, 11:51 AM EDT - Market open
LifeStance Health Group Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Buy" and an average price target of $11.7. The average 1-year stock price forecast is 5.07% higher than the current stock price, while the lowest is $9.00 (-19.17%) and the highest is $14 (+25.73%).
Price Target: $11.7 (+5.07%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for LifeStance Health Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Buy Maintains $14 | Buy | Maintains | $14 | +25.73% | Jul 16, 2026 |
| Barclays | Barclays | Buy Maintains $9 → $13 | Buy | Maintains | $9 → $13 | +16.75% | Jul 14, 2026 |
| KeyBanc | KeyBanc | Buy Maintains $11 → $13 | Buy | Maintains | $11 → $13 | +16.75% | Jul 13, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 10, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Initiates $9 | Hold | Initiates | $9 | -19.17% | Jun 6, 2026 |
Financial Forecast
Revenue This Year
1.66B
from 1.42B
Increased by 16.80%
Revenue Next Year
1.90B
from 1.66B
Increased by 14.27%
EPS This Year
0.31
from 0.18
Increased by 70.75%
EPS Next Year
0.39
from 0.31
Increased by 25.87%
EPS and Forward PE are based on non-GAAP adjusted numbers.